DIMENSION? CLINICAL CHEMISTRY SYSTEM 6L119UL

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,06 report with the FDA on 2014-12-22 for DIMENSION? CLINICAL CHEMISTRY SYSTEM 6L119UL manufactured by Siemens Healthcare Diagnostics Inc - Glasgow.

Event Text Entries

[18271554] A group of discrepant elevated methotrexate results was obtained on multiple samples from an individual patient. The results were reported to the physician who questioned the results. The samples had been run and results reported on dilutions contrary to instructions for use directions. It is unknown if patient treatment was altered as a result of the discrepant elevated methotrexate results. There was no report of adverse health consequences as a result of the discrepant elevated methotrexate results.
Patient Sequence No: 1, Text Type: D, B5


[18460948] Analysis of the instrument and instrument data indicates that the cause for the discrepant elevated methotrexate reported result is user error (non-standard use). The account performed dilutions as prescribed in the methotrexate ifu but reported result of dilutions beyond the minimal dilution that provided the first unflagged results which would provide the appropriate result. The instructions for use for the methotrexate assay contains the following information: the emit methotrexate assay can be used to analyze samples containing 0. 3-2600 umol/l methotrexate, quantitation of concentrations less than 0. 3 umol/l is not recommended. Patient samples and calibrators containing 0. 3 - 2 umol/l methotrexate are assayed according to the primary protocol. Samples containing more than 2 umol/l methotrexate can be brought within the range of the standard curve by using a calibrated pipette to serially dilute them 1:6 with buffer solution. Additionally it states: when a value for the specimen is between 0. 3 and 2 umol/l, multiply the observed value by the corresponding adjustment factor for the tube. Additionally it states: a serum methotrexate concentration above 5 umol/l at 24 hours after high dose therapy generally indicates a risk of toxicity. The account uses a non-standard practice of diluting all samples with the secondary protocol regardless if the original undiluted sample gave a result within the 0. 3 to 2 umol/l assay range. In the case of the 8am (b)(6) 2014 sample, the account reported a discrepant elevated result from a dilution above the true value which should have been reported from the undiluted sample. The instrument is performing within specifications. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2517506-2014-00363
MDR Report Key4349343
Report Source01,05,06
Date Received2014-12-22
Date of Report2014-12-04
Date of Event2014-12-03
Date Mfgr Received2014-12-04
Date Added to Maude2015-01-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactJAMES MORGERA
Manufacturer StreetGLASGOW BUSINESS COMMUNITY PO BOX 6101
Manufacturer CityNEWARK DE 197146101
Manufacturer CountryUS
Manufacturer Postal197146101
Manufacturer Phone3026318356
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
Manufacturer StreetGLASGOW BUSINESS COMMUNITY 500 GBC DRIVE
Manufacturer CityNEWARK DE 19714
Manufacturer CountryUS
Manufacturer Postal Code19714
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameDIMENSION? CLINICAL CHEMISTRY SYSTEM
Generic NameMETHOTREXATE ASSAY
Product CodeLAO
Date Received2014-12-22
Catalog Number6L119UL
Lot NumberNOT PROVIDED
OperatorMEDICAL TECHNOLOGIST
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
Manufacturer AddressGLASGOW BUSINESS COMMUNITY 500 GBC DRIVE NEWARK DE 19714 US 19714


Patients

Patient NumberTreatmentOutcomeDate
10 2014-12-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.